TY - JOUR
T1 - Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix
AU - Sevin, Bernd Uwe
AU - Method, Michael W.
AU - Nadji, Mehrdad
AU - Lu, Ying
AU - Averette, Hervy A.
PY - 1996/4/15
Y1 - 1996/4/15
N2 - BACKGROUND. This study was performed to identify pathologic and clinical features that best predict disease free survival of patients with early stage small cell carcinoma of the cervix treated by radical hysterectomy. METHODS. Three hundred and seventy patients with cervical carcinoma were analyzed retrospectively to define those variables that best predict disease free survival (DFS). Variables included age, weight, race, marital status, economic status, tumor size, depth of invasion (DI), lymph-vascular space involvement (LVSI), cell type, tumor grade, lymph node metastasis (LNM), and total number of lymph nodes removed. Patients with lymph node metastasis, parametrial involvement, and positive or close surgical margins were offered postoperative radiation. RESULTS. Twelve patients were found to have small cell carcinoma (3.2%). One patient had microinvasive carcinoma of the cervix (MIC) as defined by the Society of Gynecologic Oncologists with a depth of invasion of 3 mm or less and no lymph-vascular space invasion, and has been reported previously. A detailed analysis of the other patients with nonsmall cell carcinoma is presented separately. Five patients achieved a DFS of at least 5 years, whereas 7 patients died with disease. Excluding the patient with MIC, the 5-year DFS rate was 36.4%. CONCLUSIONS. Relative to other cell types, small cell carcinoma of the cervix is an aggressive neoplasm with a higher rate of LVSI and LNM despite smaller DI and tumor size. These data suggest that multimodality therapy, combining radical surgery and radiation with cytotoxic chemotherapy, may provide these patients with the best chance for cure.
AB - BACKGROUND. This study was performed to identify pathologic and clinical features that best predict disease free survival of patients with early stage small cell carcinoma of the cervix treated by radical hysterectomy. METHODS. Three hundred and seventy patients with cervical carcinoma were analyzed retrospectively to define those variables that best predict disease free survival (DFS). Variables included age, weight, race, marital status, economic status, tumor size, depth of invasion (DI), lymph-vascular space involvement (LVSI), cell type, tumor grade, lymph node metastasis (LNM), and total number of lymph nodes removed. Patients with lymph node metastasis, parametrial involvement, and positive or close surgical margins were offered postoperative radiation. RESULTS. Twelve patients were found to have small cell carcinoma (3.2%). One patient had microinvasive carcinoma of the cervix (MIC) as defined by the Society of Gynecologic Oncologists with a depth of invasion of 3 mm or less and no lymph-vascular space invasion, and has been reported previously. A detailed analysis of the other patients with nonsmall cell carcinoma is presented separately. Five patients achieved a DFS of at least 5 years, whereas 7 patients died with disease. Excluding the patient with MIC, the 5-year DFS rate was 36.4%. CONCLUSIONS. Relative to other cell types, small cell carcinoma of the cervix is an aggressive neoplasm with a higher rate of LVSI and LNM despite smaller DI and tumor size. These data suggest that multimodality therapy, combining radical surgery and radiation with cytotoxic chemotherapy, may provide these patients with the best chance for cure.
KW - neuroendocrine tumors
KW - radiation therapy
KW - radical hysterectomy
KW - small cell carcinoma
UR - http://www.scopus.com/inward/record.url?scp=0030008046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030008046&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1097-0142(19960415)77:8<1489::AID-CNCR10>3.0.CO;2-W
DO - 10.1002/(SICI)1097-0142(19960415)77:8<1489::AID-CNCR10>3.0.CO;2-W
M3 - Article
C2 - 8608533
AN - SCOPUS:0030008046
VL - 77
SP - 1489
EP - 1493
JO - Cancer
JF - Cancer
SN - 0008-543X
IS - 8
ER -